期刊文献+

用3种剂量A型肉毒毒素治疗原发性三叉神经痛的疗效比较 被引量:7

Three doses of botulinum toxin type A for treatment of classic trigeminal neuralgia
下载PDF
导出
摘要 目的:观察3种剂量A型肉毒毒素治疗三叉神经痛的疗效,焦虑、抑郁、睡眠变化及其不良反应。方法:选取原发性三叉神经痛患者87例,随机分为25 U/mL组(28例)、50 U/mL组(31例)和75 U/mL组(28例)3种剂量组,分别于疼痛部位多点皮内注射不同剂量的A型肉毒毒素,对每位患者治疗前及治疗后8周内每周进行视觉模拟(VAS)评分、焦虑评分、抑郁评分、睡眠干扰评分,并于第8周进行患者总体印象改变评分,观察疗效及其安全性。结果:3组治疗后疼痛治疗有效率差异无统计学意义(χ2=3.482,P=0.175)。治疗后3组焦虑、抑郁和睡眠评分均较各自治疗前显著降低,但3组有效率比较差异无统计学意义。治疗后3组患者总体印象改变改善率差异无统计学意义(χ2=1.345,P=0.510)。7例出现注射部位短暂性的肌肉松弛,2例出现注射部位肿胀,均自行消失,未进行处理,未见全身性不良反应。结论:不同剂量A型肉毒毒素治疗三叉神经痛均有效。 Aim: To observe the efficacy,anxiety,depression,sleep interference and adverse reaction of botulinum toxin type A( BTX-A) with three doses for the treatment of trigeminal neuralgia. Methods: Eighty seven patients with trigeminal neuralgia were randomized into three dose groups: BTX-A 25 U /mL( n = 28),BTX-A 50 U /mL( n = 31),BTXA 75 U /mL( n = 28) and local multi-point injection of different doses of BTX-A was administrated. Follow-up visits were conducted every week after the injection,and the overall duration of the study for each patient was 8 weeks to observe the visual analogue scale( VAS),anxiety,depression and sleep interference score and the patient global impression of change( PGIC) scale at endpoint,assessing the efficacy and safety. Results: There was no significant difference in VAS efficacy among three groups( χ2= 3. 482,P = 0. 175). The scores of anxiety,depression and sleep interference of three groups reduced significantly compared to baseline screening period,but there were no significant differences among three groups.There were no significant differences in PGIC among three groups( χ2= 1. 345,P = 0. 510). Seven patients experienced transient muscle relaxation and two patients experienced edema in the injection area. All adverse reaction disappeared automatically without treatment,and there was no systemic adverse reaction. Conclusion: Three different doses of BTX-A for treatment of trigeminal neuralgia were all efficient,and there were no significant differences in multiple observation indexes among three groups.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2014年第4期536-539,共4页 Journal of Zhengzhou University(Medical Sciences)
基金 河南省教育厅自然科学研究资助计划项目2011A320038 河南省卫生厅课题201203006
关键词 三叉神经痛 A型肉毒毒素 焦虑 抑郁 睡眠障碍 trigeminal neuralgia botulinum toxin type A anxiety depression sleep interference
  • 相关文献

参考文献19

  • 1Olesen J, Steiner TJ. The international classification of headache disorders, 2nd edn (ICDH-II) [ J ]. J Neurol Neurosurg Psychiatry, 2004,75 ( 6 ) : 808.
  • 2Macianskyte D, Januzis G, Kubilius R, et al. Associations between chronic pain and depressive symptoms in patients with trigeminal neuralgia[ J ]. Medicina ( Kaunas ) , 2011, 47(7) :386.
  • 3Wu CJ,Lian YJ,Zheng YK,et al. Botulinurn toxin type A for the treatment of trigerninal neuralgia: results from a randomized, double-blind, placebo-controlled trial [ J ]. Cephalalgia ,2012,32 (6) :443.
  • 4Mieheli F, Scorticati MC, Raina G. Beneficial effects of bot- ulinum toxin type a for patients with painful tic convulsif [ J ]. Clin Neuropharmaco1,2002,25 ( 5 ) :260.
  • 5Piovesan EJ,Teive HG, Kowacs PA, et al. An open study of botulinum-A toxin treatment of trigeminal neuralgia [ J ]. Neurology ,2005,65 ( 8 ) : 1306.
  • 6Ttirk U, Ilhan S, Alp R, et al. Botulinum toxin and intracta- ble trigerninal neuralgia [ J ]. Clin Neuropharmacol, 2005, 28(4) :161.
  • 7Ztfiiga C, Diaz S, Piedimonte F, et al. Beneficial effects of botulinum toxin type A in trigeminal neuralgia [ J ]. Arq Neuropsiquiatr, 2008,66 ( 3 A ) : 500.
  • 8Bohluli B, Motamedi MH, Bagheri SC, et al. Use of botuli- num toxin A for drug-refractory trigeminal neuralgia: pre- liminary report[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod ,2011,111 ( 1 ) :47.
  • 9Revill SI,Robinson JO, Rosen M, et al. The rehability of a linear analogue for evaluating pain [ J ]. Anaesthesia, 1976,31(9) :1191.
  • 10连亚军,魏红玲,张博爱,刘洪波,许予明,方树友,李增富,方桂远,卢宏,贾延劼,赵莘瑜,魏建科,贾延颉,张璐,宋波.A型肉毒毒素治疗面肌痉挛和局限性肌张力障碍795例[J].郑州大学学报(医学版),2009,44(2):440-442. 被引量:14

二级参考文献23

  • 1连亚军,魏红玲,张博爱,刘洪波,许予明,方树友,李增富,方桂远,卢宏,贾延劼,赵莘瑜,魏建科,贾延颉,张璐,宋波.A型肉毒毒素治疗面肌痉挛和局限性肌张力障碍795例[J].郑州大学学报(医学版),2009,44(2):440-442. 被引量:14
  • 2卫华,王玉平,李莉萍,张瑞华,张小娟.颈部肌张力障碍临床分型及肉毒毒素疗效[J].中华神经科杂志,2006,39(1):52-54. 被引量:11
  • 3吴逸雯,Vial C,Broussolle E,谢晶,陈生弟.A型肉毒毒素治疗睑肌痉挛伴发睁眼性失用的疗效观察[J].临床神经病学杂志,2006,19(3):221-223. 被引量:2
  • 4Headache Classification Subcommittee of the International Headache Society. The international classifieation of headaehe disorders: 2nd ed[J]. Cephalalgia,2004;24(Suppl 1):9-160.
  • 5Micheli F, Scorticati MC, Raina G. Beneficial effects of botulinum toxin type a for palients with painful tie convulsif[J]. Clin Neuropharmacol,2002,25:260-262.
  • 6Allam N,Brasil-Neto,Brown G,et al.Injection of botulinum toxin type A produce pain alleviation in intractable trigeminal neuralgia[J].Clin J Pain,2005,21:182-184.
  • 7Turk U,llhan S,AIp R,et al.Botulinum toxin and intractable trigeminal neuralgia[J].Clin Neuropharmacol, 2005;28:161-162.
  • 8Zuniga C, Diaz S, Piadimonta F, at al.Benafiaial affects of botulinum toxin type A in trigaminal neuralgia[J].Arq Neuropsiquiatr,2008,66(3 - A):500-503.
  • 9Bahhdi B, Motamedi MH, Bagheri SC,et al.Use of botulinum lexin A for drug-refractory trigeminal neuralgia: preliminary report[J]. Oral Surg Oral Med Oral Pathol Oral Radial Endod, 2011,111(1):47-50.
  • 10Ngeow WC. Nair R. injection of botulinum toxin type A (BOTOX) into trigger zone of trigeminal neuralgia as a means to control pain[J].Oral Snrg Oral Med Oral Pathol Oral Radiol Endod, 2010, 109:e47-e50.

共引文献21

同被引文献102

  • 1罗蓉,毛萌.肉毒毒素在脑性瘫痪康复中的应用[J].实用儿科临床杂志,2005,20(6):594-596. 被引量:16
  • 2余丹,励建安.A型肉毒毒素在治疗肌肉痉挛中的临床应用[J].中国康复医学杂志,2005,20(11):857-859. 被引量:6
  • 3Turton K, Chaddock JA, Acharya KR. Botulinum and tetanus neuro- toxins: structure, function and therapeutic utility [J]. Trends Bio- chem Sci, 2002, 27(11): 552-558.
  • 4Jankovic J. Botulinum toxin in clinical practice [J]. J Neurol Neuro- surg Psychiatry, 2004, 75(7):951-957.
  • 5Singhi P, Ray M. Botulinum toxin in children with cerebral palsy [J]. Indian J Pediatr, 2004, 71(12):1087-1091.
  • 6Dhaked RK, Singh MK, Singh P, et al. Botulinum toxin: bioweapon & magic drug [J]. Indian J Med Res, 2010, 132: 489-503.
  • 7He J, Wang T, Dong J. A close positive correlation between malodor and sweating as a marker for the treatment of axillary bromhidrosis with Botulinum toxin A [J]. J Dermatolog Treat, 2012, 23(6):461- 464.
  • 8Aoki KR. Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A [J]. Neurotoxicology, 2005, 26(5): 785-793.
  • 9Sim WS. Application of botulinum toxin in pain management [J]. Korean J Pain, 2011, 24(1):1-6.
  • 10Dodick DW. Botulinum neurotoxin for the treatment of migraine and other primary headache disorders: from bench to bedside [J]. Head- ache, 2003, 43 Suppl 1:$25-$33.

引证文献7

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部